Dow Down 1.39% Nasdaq Down 1.65%

NovaBay Pharmaceuticals, Inc. (NBY)

-NYSE MKT
0.79 Down 0.05(5.95%) 3:37PM EDT - Nasdaq Real Time Price
Prev Close:0.84
Open:0.85
Bid:0.77 x 600
Ask:0.78 x 100
1y Target Est:1.45
Beta:0.89
Next Earnings Date:N/A
Day's Range:0.77 - 0.85
52wk Range:0.69 - 1.87
Volume:184,056
Avg Vol (3m):336,941
Market Cap:40.12M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBY

Comparison

Symbol% ChgMkt Cap
NBYDown 5.95%40.12M
ABTDown 1.05%61.88B
PFEDown 1.42%184.84B
SNNDown 1.46%14.83B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback